Immuneering logo
Immuneering
IMRX | NASDAQ
Chart Builder DCF Calculator
$3.52
-$0.19 (-5.12%)
At close: Nov 16, 2026, 4:00 PM ET
$3.46
-$0.06 (-1.70%)
Pre-market: Nov 17, 2026, 5:36 AM ET

Immuneering Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-54.89B -17.27M -13.46M -11.58M -14.96M -14.43M -15.05M -18.05M -14.6M -14.08M -14.31M -15.08M -12.6M -12.19M -13.6M -13.25M -12.84M -11.53M -12.9M -10.78M -8.53M -7.99M -6.23M
273.75M 91.77K 88.72K 83.21K 86.16K 91.84K 92.58K 93.43K 96.27K 97.85K 97.53K 97.07K 85.61K 85.56K 83.84K 189.28K 75.39K 202.36K 200.63K 52.5K 37.57K 35.11K 33.89K
5.32B 1.63M 1.64M 1.64M 1.46M 1.52M 1.69M 1.72M 1.64M 1.66M 1.47M 1.64M 1.48M 1.33M 1.27M 1.05M 1.07M 1.05M 897.65K 632.58K 636.81K 351.01K 182.23K
– -2.39M -6.3M 9.16K 2.33M 2.1M -214.66K 1.64M 21.86K 331.31K -2.8M 1.71M -16.48K 94.34K -1.67M -400.24K -158.68K 1.08M -800.92K 1.24M -1.57M 1.1M -22.27K
-2.39B -484.82K -312.96K -64.21K 87.27K 85.2K 83.18K 30.99K 46.55K 69.92K -71.48K -313.03K -201.81K -6.24K -80.51K -214.19K 32.68K 40.91K 103.53K -185.79K 8.55K – –
– – – – – – – – – – – – – – – – – – – – – – –
6.85M -465.82K -6.38M 82.57K 1.36M 3.29M -902.53K 1.69M -657.59K 724.49K -2.68M 1.88M -794.68K 27.06K -2.09M 473.7K 1.05M 782.34K -586.47K 1.05M -1.18M 1.16M -126.31K
-51.69B -16.5M -18.43M -9.84M -11.98M -9.45M -14.08M -14.51M -13.47M -11.53M -15.49M -11.78M -12.03M -10.75M -14.42M -11.75M -10.62M -9.45M -12.28M -9.24M -9.03M -6.44M -6.14M
-122.35M -27.37K -79.93K -123.91K -7.26K -2.12K -8.95K -9.36K -5.27K -32.77K -37.48K -170.92K -57.15K -86.69K -27.99K -69.31K -393.13K -165K -115.05K -13.05K -11.34K -19.82K -16.56K
– – – – – – – – – – – – – – – – – – – – – – –
-84.09B -11.99M -71.99M -88.6M – – – – – – – -15.75M -28.91M – – -12.38M -19.74M -10.01M -7.98M -22.87M -52.76M – –
65.14B 22.5M 9M – – – – 5.5M – 5M 21.43M 19.05M 5M 9.25M 19M 20.6M 19.25M 32.33M 20.5M – – – –
– – – – – – – – -5.41M – – – – – – – – – – 70.35K – – –
-19.07B 10.48M -63.07M -88.72M -7.26K -2.12K -8.95K 5.49M -5.42M 4.97M 21.39M 3.13M -23.97M 9.16M 18.97M 8.15M -880.08K 22.15M 12.4M -22.81M -52.77M -19.82K -16.56K
– – – – – – – – – – – – – – – – – – – – – – –
317.46M – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
425.34M – – -587.36K -3.07M -64.01K – 374.65K 127.19K – – – – – – – – – – – – 979.75K –
425.34M 24.61K 180.76K -357.52K 213.19M -61.96K 13.81M -40.99K 4.36M – 979.92K 7.84K 21.45K 28.17M 239.41K -184.68K -17.21K 27.78K 193.11K 7.52K 118.49M 25.77M –
58.19B -6M -81.32M -98.92M 201.21M -9.51M -279.02K -9.06M -14.52M -6.56M 6.88M -8.63M -35.98M 26.59M 4.79M -3.78M -11.52M 12.73M 316.92K -32.04M 56.68M 19.31M -6.16M
-51.81B -16.53M -18.51M -9.96M -11.98M -9.45M -14.09M -14.52M -13.48M -11.56M -15.53M -11.95M -12.08M -10.84M -14.45M -11.82M -11.02M -9.61M -12.4M -9.25M -9.05M -6.46M -6.16M
-57.13B -18.16M -20.15M -11.6M -13.44M -10.97M -15.78M -16.24M -15.12M -13.22M -17M -13.59M -13.56M -12.17M -15.72M -12.87M -12.08M -10.67M -13.29M -9.88M -9.68M -6.81M -6.34M
-122.35M -27.37K -79.93K -123.91K -7.26K -2.12K -8.95K -9.36K -5.27K -32.77K -37.48K -170.92K -57.15K -86.69K -27.99K -69.31K -393.13K -165K -115.05K -13.05K -11.34K – –
– – – – – – – – – – – – – – – – – – – – – -19.82K -16.56K
-51.81B -16.53M -18.51M -9.96M -11.98M -9.45M -14.09M -14.52M -13.48M -11.56M -15.53M -11.95M -12.08M -10.84M -14.45M -11.82M -11.02M -9.61M -12.4M -9.25M -9.05M -6.44M -6.14M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.